These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Gambrell RD Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116 [TBL] [Abstract][Full Text] [Related]
3. Benefits and risks of hormone replacement therapy (HRT). Breckwoldt M; Keck C; Karck U J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):205-8. PubMed ID: 7626455 [TBL] [Abstract][Full Text] [Related]
4. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks. Moskowitz D Altern Med Rev; 2006 Sep; 11(3):208-23. PubMed ID: 17217322 [TBL] [Abstract][Full Text] [Related]
6. Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical? Shapiro S Climacteric; 2015 Jun; 18(3):333-5. PubMed ID: 25651904 [No Abstract] [Full Text] [Related]
9. Hormone replacement therapy and the menopause. Australian Menopause Society. MacLennan AH Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437 [No Abstract] [Full Text] [Related]
10. Hormone replacement therapy: estrogen after menopause. Gibaldi M Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594 [No Abstract] [Full Text] [Related]
11. The adverse effects of hormonal therapy. Bush TL Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931 [TBL] [Abstract][Full Text] [Related]
12. Exogenous progestins and breast cancer. Stanford JL; Thomas DB Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216 [TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone therapy and breast cancer. Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723 [TBL] [Abstract][Full Text] [Related]
14. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis. Asi N; Mohammed K; Haydour Q; Gionfriddo MR; Vargas OL; Prokop LJ; Faubion SS; Murad MH Syst Rev; 2016 Jul; 5(1):121. PubMed ID: 27456847 [TBL] [Abstract][Full Text] [Related]
15. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy. Colditz GA J Womens Health; 1999 Apr; 8(3):347-57. PubMed ID: 10326989 [TBL] [Abstract][Full Text] [Related]
16. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Norman RJ; Flight IH; Rees MC Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730 [TBL] [Abstract][Full Text] [Related]
17. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001 [TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy in the climacteric]. Canto de Cetina TE Rev Invest Clin; 1995; 47(1):49-61. PubMed ID: 7777716 [TBL] [Abstract][Full Text] [Related]
19. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]